JIM
CRL icon

Jensen Investment Management’s Charles River Laboratories CRL Stock Holding History

Jensen Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,180
Closed -$2.4M – 86
2024
Q3 		$2.4M Sell
12,180
-3,730
-23% -$775K 0.02% 79
2024
Q2 		$3.29M Sell
15,910
-7,770
-33% -$1.76M 0.03% 72
2024
Q1 		$6.42M Sell
23,680
-1,850
-7% -$442K 0.05% 48
2023
Q4 		$6.04M Hold
25,530
– – 0.05% 48
2023
Q3 		$5M Buy
25,530
+550
+2% +$113K 0.04% 54
2023
Q2 		$5.25M Sell
24,980
-800
-3% -$159K 0.04% 57
2023
Q1 		$5.11M Buy
25,780
+2,700
+12% +$612K 0.04% 57
2022
Q4 		$5.03M Buy
23,080
+5,710
+33% +$1.25M 0.04% 54
2022
Q3 		$3.42M Buy
17,370
+8,710
+101% +$1.88M 0.03% 64
2022
Q2 		$1.85M Buy
+8,660
New +$2.12M 0.02% 76

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Jensen Investment Management's CRL Position: Q4 2024 in Review

Jensen Investment Management sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 12,180 shares — an estimated $2.4M sold.

Jensen Investment Management first reported a position in CRL in Q2 2022 and held it in 10 quarters. The position peaked at $6.42M in Q1 2024. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Jensen Investment Management reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Jensen Investment Management sold 12,180 Charles River Laboratories shares in Q4 2024, an estimated $2.4M.
  • Jensen Investment Management first reported a position in Charles River Laboratories in Q2 2022 and held it in 10 quarters.
  • Jensen Investment Management's Charles River Laboratories position peaked at $6.42M in Q1 2024.
  • 637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Jensen Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.